<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109-molecules-25-04032">
 <label>109.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fabian</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Garber</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Dooley</surname>
    <given-names>W.C.</given-names>
   </name>
   <name>
    <surname>Yee</surname>
    <given-names>L.D.</given-names>
   </name>
   <name>
    <surname>Klemp</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Nydegger</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Powers</surname>
    <given-names>K.R.</given-names>
   </name>
   <name>
    <surname>Kreutzjans</surname>
    <given-names>A.L.</given-names>
   </name>
   <name>
    <surname>Zalles</surname>
    <given-names>C.M.</given-names>
   </name>
  </person-group>
  <article-title>Randomized phase IIB trial of the lignan secoisolariciresinol diglucoside in pre-menopausal women at increased risk for development of breast cancer</article-title>
  <source>Cancer Prev. Res.</source>
  <year>2020</year>
  <fpage>1</fpage>
  <lpage>32</lpage>
  <pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-20-0050</pub-id>
 </element-citation>
</ref>
